Pharmafile - Sales and Marketing News
The UK Health Security Agency (UKHSA) has released updated guidance on monkeypox now recommending that those who have had “unprotected direct contact...
Positive results for a vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine...
Eli Lilly’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide has...
The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at £9.35 until next...
AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the treatment of...
Scientists from The Children's Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) have lower...
Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium bitartrate), which...
The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a month following the Druham...
The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.
Shionogi has announced new results from two late-breaking presentations of S-217622. This is an investigational 3CL protease inhibitor that was...